A5058s
Status:Completed
Phase:III
Principal Investigator(s):Fred Valentine & Laurence Peiperl
Objective:(This study is currently being redesigned and the purpose may be revised.) The purpose of this study is to look at the effects of the HIV vaccine Remune on viral load (level of HIV in the blood) and on the way the immune system responds to HIV.
Prevention Option(s):Therapeutic Vaccines
Study Design:Controlled, Double-blind, Placebo, Randomized
Arms and Assigned Interventions
DescriptionALVAC vCP1452
Mode of Delivery
ARMsExperimental
Official Code:
NCT00005758
Trial Sponsors:
NIAID
Start Date
End Date
May 31, 2000
none
Enrollment:472
Age range:
14 Years ↔
any
Population:Cisgender Men, Cisgender Women, People Living with HIV